An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.
Identifieur interne : 001743 ( PubMed/Corpus ); précédent : 001742; suivant : 001744An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.
Auteurs : Maria Rohm ; Michaela Sch Fer ; Victor Laurent ; Bilgen Ekim Üstünel ; Katharina Niopek ; Carolyn Algire ; Oksana Hautzinger ; Tjeerd P. Sijmonsma ; Annika Zota ; Dasa Medrikova ; Natalia S. Pellegata ; Mikael Ryden ; Agné Kulyte ; Ingrid Dahlman ; Peter Arner ; Natasa Petrovic ; Barbara Cannon ; Ez-Zoubir Amri ; Bruce E. Kemp ; Gregory R. Steinberg ; Petra Janovska ; Jan Kopecky ; Christian Wolfrum ; Matthias Blüher ; Mauricio Berriel Diaz ; Stephan HerzigSource :
- Nature medicine [ 1546-170X ] ; 2016.
English descriptors
- KwdEn :
- AMP-Activated Protein Kinases (metabolism), AMP-Activated Protein Kinases (pharmacology), Adipocytes, White (drug effects), Adipocytes, White (metabolism), Adipose Tissue, White (drug effects), Adipose Tissue, White (metabolism), Animals, Apoptosis Regulatory Proteins (drug effects), Apoptosis Regulatory Proteins (metabolism), Cachexia (etiology), Cachexia (metabolism), Cells, Cultured, In Vitro Techniques, Lipid Metabolism (drug effects), Lipogenesis (drug effects), Lipolysis (drug effects), Mice, Neoplasms (complications), Neoplasms (metabolism), Peptide Fragments (pharmacology), Thermogenesis (drug effects), Uncoupling Protein 1 (drug effects), Uncoupling Protein 1 (metabolism).
- MESH :
- chemical , drug effects : Apoptosis Regulatory Proteins, Uncoupling Protein 1.
- chemical , metabolism : AMP-Activated Protein Kinases, Apoptosis Regulatory Proteins, Uncoupling Protein 1.
- chemical , pharmacology : AMP-Activated Protein Kinases, Peptide Fragments.
- complications : Neoplasms.
- drug effects : Adipocytes, White, Adipose Tissue, White, Lipid Metabolism, Lipogenesis, Lipolysis, Thermogenesis.
- etiology : Cachexia.
- metabolism : Adipocytes, White, Adipose Tissue, White, Cachexia, Neoplasms.
- Animals, Cells, Cultured, In Vitro Techniques, Mice.
Abstract
Cachexia represents a fatal energy-wasting syndrome in a large number of patients with cancer that mostly results in a pathological loss of skeletal muscle and adipose tissue. Here we show that tumor cell exposure and tumor growth in mice triggered a futile energy-wasting cycle in cultured white adipocytes and white adipose tissue (WAT), respectively. Although uncoupling protein 1 (Ucp1)-dependent thermogenesis was dispensable for tumor-induced body wasting, WAT from cachectic mice and tumor-cell-supernatant-treated adipocytes were consistently characterized by the simultaneous induction of both lipolytic and lipogenic pathways. Paradoxically, this was accompanied by an inactivated AMP-activated protein kinase (Ampk), which is normally activated in peripheral tissues during states of low cellular energy. Ampk inactivation correlated with its degradation and with upregulation of the Ampk-interacting protein Cidea. Therefore, we developed an Ampk-stabilizing peptide, ACIP, which was able to ameliorate WAT wasting in vitro and in vivo by shielding the Cidea-targeted interaction surface on Ampk. Thus, our data establish the Ucp1-independent remodeling of adipocyte lipid homeostasis as a key event in tumor-induced WAT wasting, and we propose the ACIP-dependent preservation of Ampk integrity in the WAT as a concept in future therapies for cachexia.
DOI: 10.1038/nm.4171
PubMed: 27571348
Links to Exploration step
pubmed:27571348Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.</title>
<author><name sortKey="Rohm, Maria" sort="Rohm, Maria" uniqKey="Rohm M" first="Maria" last="Rohm">Maria Rohm</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sch Fer, Michaela" sort="Sch Fer, Michaela" uniqKey="Sch Fer M" first="Michaela" last="Sch Fer">Michaela Sch Fer</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Laurent, Victor" sort="Laurent, Victor" uniqKey="Laurent V" first="Victor" last="Laurent">Victor Laurent</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ustunel, Bilgen Ekim" sort="Ustunel, Bilgen Ekim" uniqKey="Ustunel B" first="Bilgen Ekim" last="Üstünel">Bilgen Ekim Üstünel</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Niopek, Katharina" sort="Niopek, Katharina" uniqKey="Niopek K" first="Katharina" last="Niopek">Katharina Niopek</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Algire, Carolyn" sort="Algire, Carolyn" uniqKey="Algire C" first="Carolyn" last="Algire">Carolyn Algire</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hautzinger, Oksana" sort="Hautzinger, Oksana" uniqKey="Hautzinger O" first="Oksana" last="Hautzinger">Oksana Hautzinger</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sijmonsma, Tjeerd P" sort="Sijmonsma, Tjeerd P" uniqKey="Sijmonsma T" first="Tjeerd P" last="Sijmonsma">Tjeerd P. Sijmonsma</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zota, Annika" sort="Zota, Annika" uniqKey="Zota A" first="Annika" last="Zota">Annika Zota</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Medrikova, Dasa" sort="Medrikova, Dasa" uniqKey="Medrikova D" first="Dasa" last="Medrikova">Dasa Medrikova</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pellegata, Natalia S" sort="Pellegata, Natalia S" uniqKey="Pellegata N" first="Natalia S" last="Pellegata">Natalia S. Pellegata</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ryden, Mikael" sort="Ryden, Mikael" uniqKey="Ryden M" first="Mikael" last="Ryden">Mikael Ryden</name>
<affiliation><nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kulyte, Agne" sort="Kulyte, Agne" uniqKey="Kulyte A" first="Agné" last="Kulyte">Agné Kulyte</name>
<affiliation><nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dahlman, Ingrid" sort="Dahlman, Ingrid" uniqKey="Dahlman I" first="Ingrid" last="Dahlman">Ingrid Dahlman</name>
<affiliation><nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Arner, Peter" sort="Arner, Peter" uniqKey="Arner P" first="Peter" last="Arner">Peter Arner</name>
<affiliation><nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Petrovic, Natasa" sort="Petrovic, Natasa" uniqKey="Petrovic N" first="Natasa" last="Petrovic">Natasa Petrovic</name>
<affiliation><nlm:affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cannon, Barbara" sort="Cannon, Barbara" uniqKey="Cannon B" first="Barbara" last="Cannon">Barbara Cannon</name>
<affiliation><nlm:affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Amri, Ez Zoubir" sort="Amri, Ez Zoubir" uniqKey="Amri E" first="Ez-Zoubir" last="Amri">Ez-Zoubir Amri</name>
<affiliation><nlm:affiliation>Université Côte d'Azur, Nice, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kemp, Bruce E" sort="Kemp, Bruce E" uniqKey="Kemp B" first="Bruce E" last="Kemp">Bruce E. Kemp</name>
<affiliation><nlm:affiliation>St Vincent's Institute of Medical Research, University of Melbourne, Fitzroy, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Steinberg, Gregory R" sort="Steinberg, Gregory R" uniqKey="Steinberg G" first="Gregory R" last="Steinberg">Gregory R. Steinberg</name>
<affiliation><nlm:affiliation>Department of Medicine, Division of Endocrinology and Metabolism, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Janovska, Petra" sort="Janovska, Petra" uniqKey="Janovska P" first="Petra" last="Janovska">Petra Janovska</name>
<affiliation><nlm:affiliation>Department of Adipose Tissue Biology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kopecky, Jan" sort="Kopecky, Jan" uniqKey="Kopecky J" first="Jan" last="Kopecky">Jan Kopecky</name>
<affiliation><nlm:affiliation>Department of Adipose Tissue Biology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wolfrum, Christian" sort="Wolfrum, Christian" uniqKey="Wolfrum C" first="Christian" last="Wolfrum">Christian Wolfrum</name>
<affiliation><nlm:affiliation>Swiss Federal Institute of Technology, Institute of Food Nutrition and Health, Schwerzenbach, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bluher, Matthias" sort="Bluher, Matthias" uniqKey="Bluher M" first="Matthias" last="Blüher">Matthias Blüher</name>
<affiliation><nlm:affiliation>Department of Medicine, University of Leipzig, Leipzig, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Berriel Diaz, Mauricio" sort="Berriel Diaz, Mauricio" uniqKey="Berriel Diaz M" first="Mauricio" last="Berriel Diaz">Mauricio Berriel Diaz</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Herzig, Stephan" sort="Herzig, Stephan" uniqKey="Herzig S" first="Stephan" last="Herzig">Stephan Herzig</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27571348</idno>
<idno type="pmid">27571348</idno>
<idno type="doi">10.1038/nm.4171</idno>
<idno type="wicri:Area/PubMed/Corpus">001743</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001743</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.</title>
<author><name sortKey="Rohm, Maria" sort="Rohm, Maria" uniqKey="Rohm M" first="Maria" last="Rohm">Maria Rohm</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sch Fer, Michaela" sort="Sch Fer, Michaela" uniqKey="Sch Fer M" first="Michaela" last="Sch Fer">Michaela Sch Fer</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Laurent, Victor" sort="Laurent, Victor" uniqKey="Laurent V" first="Victor" last="Laurent">Victor Laurent</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ustunel, Bilgen Ekim" sort="Ustunel, Bilgen Ekim" uniqKey="Ustunel B" first="Bilgen Ekim" last="Üstünel">Bilgen Ekim Üstünel</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Niopek, Katharina" sort="Niopek, Katharina" uniqKey="Niopek K" first="Katharina" last="Niopek">Katharina Niopek</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Algire, Carolyn" sort="Algire, Carolyn" uniqKey="Algire C" first="Carolyn" last="Algire">Carolyn Algire</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hautzinger, Oksana" sort="Hautzinger, Oksana" uniqKey="Hautzinger O" first="Oksana" last="Hautzinger">Oksana Hautzinger</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sijmonsma, Tjeerd P" sort="Sijmonsma, Tjeerd P" uniqKey="Sijmonsma T" first="Tjeerd P" last="Sijmonsma">Tjeerd P. Sijmonsma</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zota, Annika" sort="Zota, Annika" uniqKey="Zota A" first="Annika" last="Zota">Annika Zota</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Medrikova, Dasa" sort="Medrikova, Dasa" uniqKey="Medrikova D" first="Dasa" last="Medrikova">Dasa Medrikova</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pellegata, Natalia S" sort="Pellegata, Natalia S" uniqKey="Pellegata N" first="Natalia S" last="Pellegata">Natalia S. Pellegata</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ryden, Mikael" sort="Ryden, Mikael" uniqKey="Ryden M" first="Mikael" last="Ryden">Mikael Ryden</name>
<affiliation><nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kulyte, Agne" sort="Kulyte, Agne" uniqKey="Kulyte A" first="Agné" last="Kulyte">Agné Kulyte</name>
<affiliation><nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dahlman, Ingrid" sort="Dahlman, Ingrid" uniqKey="Dahlman I" first="Ingrid" last="Dahlman">Ingrid Dahlman</name>
<affiliation><nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Arner, Peter" sort="Arner, Peter" uniqKey="Arner P" first="Peter" last="Arner">Peter Arner</name>
<affiliation><nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Petrovic, Natasa" sort="Petrovic, Natasa" uniqKey="Petrovic N" first="Natasa" last="Petrovic">Natasa Petrovic</name>
<affiliation><nlm:affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cannon, Barbara" sort="Cannon, Barbara" uniqKey="Cannon B" first="Barbara" last="Cannon">Barbara Cannon</name>
<affiliation><nlm:affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Amri, Ez Zoubir" sort="Amri, Ez Zoubir" uniqKey="Amri E" first="Ez-Zoubir" last="Amri">Ez-Zoubir Amri</name>
<affiliation><nlm:affiliation>Université Côte d'Azur, Nice, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kemp, Bruce E" sort="Kemp, Bruce E" uniqKey="Kemp B" first="Bruce E" last="Kemp">Bruce E. Kemp</name>
<affiliation><nlm:affiliation>St Vincent's Institute of Medical Research, University of Melbourne, Fitzroy, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Steinberg, Gregory R" sort="Steinberg, Gregory R" uniqKey="Steinberg G" first="Gregory R" last="Steinberg">Gregory R. Steinberg</name>
<affiliation><nlm:affiliation>Department of Medicine, Division of Endocrinology and Metabolism, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Janovska, Petra" sort="Janovska, Petra" uniqKey="Janovska P" first="Petra" last="Janovska">Petra Janovska</name>
<affiliation><nlm:affiliation>Department of Adipose Tissue Biology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kopecky, Jan" sort="Kopecky, Jan" uniqKey="Kopecky J" first="Jan" last="Kopecky">Jan Kopecky</name>
<affiliation><nlm:affiliation>Department of Adipose Tissue Biology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wolfrum, Christian" sort="Wolfrum, Christian" uniqKey="Wolfrum C" first="Christian" last="Wolfrum">Christian Wolfrum</name>
<affiliation><nlm:affiliation>Swiss Federal Institute of Technology, Institute of Food Nutrition and Health, Schwerzenbach, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bluher, Matthias" sort="Bluher, Matthias" uniqKey="Bluher M" first="Matthias" last="Blüher">Matthias Blüher</name>
<affiliation><nlm:affiliation>Department of Medicine, University of Leipzig, Leipzig, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Berriel Diaz, Mauricio" sort="Berriel Diaz, Mauricio" uniqKey="Berriel Diaz M" first="Mauricio" last="Berriel Diaz">Mauricio Berriel Diaz</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Herzig, Stephan" sort="Herzig, Stephan" uniqKey="Herzig S" first="Stephan" last="Herzig">Stephan Herzig</name>
<affiliation><nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Nature medicine</title>
<idno type="eISSN">1546-170X</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AMP-Activated Protein Kinases (metabolism)</term>
<term>AMP-Activated Protein Kinases (pharmacology)</term>
<term>Adipocytes, White (drug effects)</term>
<term>Adipocytes, White (metabolism)</term>
<term>Adipose Tissue, White (drug effects)</term>
<term>Adipose Tissue, White (metabolism)</term>
<term>Animals</term>
<term>Apoptosis Regulatory Proteins (drug effects)</term>
<term>Apoptosis Regulatory Proteins (metabolism)</term>
<term>Cachexia (etiology)</term>
<term>Cachexia (metabolism)</term>
<term>Cells, Cultured</term>
<term>In Vitro Techniques</term>
<term>Lipid Metabolism (drug effects)</term>
<term>Lipogenesis (drug effects)</term>
<term>Lipolysis (drug effects)</term>
<term>Mice</term>
<term>Neoplasms (complications)</term>
<term>Neoplasms (metabolism)</term>
<term>Peptide Fragments (pharmacology)</term>
<term>Thermogenesis (drug effects)</term>
<term>Uncoupling Protein 1 (drug effects)</term>
<term>Uncoupling Protein 1 (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Apoptosis Regulatory Proteins</term>
<term>Uncoupling Protein 1</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>AMP-Activated Protein Kinases</term>
<term>Apoptosis Regulatory Proteins</term>
<term>Uncoupling Protein 1</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>AMP-Activated Protein Kinases</term>
<term>Peptide Fragments</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Adipocytes, White</term>
<term>Adipose Tissue, White</term>
<term>Lipid Metabolism</term>
<term>Lipogenesis</term>
<term>Lipolysis</term>
<term>Thermogenesis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cachexia</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Adipocytes, White</term>
<term>Adipose Tissue, White</term>
<term>Cachexia</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cells, Cultured</term>
<term>In Vitro Techniques</term>
<term>Mice</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Cachexia represents a fatal energy-wasting syndrome in a large number of patients with cancer that mostly results in a pathological loss of skeletal muscle and adipose tissue. Here we show that tumor cell exposure and tumor growth in mice triggered a futile energy-wasting cycle in cultured white adipocytes and white adipose tissue (WAT), respectively. Although uncoupling protein 1 (Ucp1)-dependent thermogenesis was dispensable for tumor-induced body wasting, WAT from cachectic mice and tumor-cell-supernatant-treated adipocytes were consistently characterized by the simultaneous induction of both lipolytic and lipogenic pathways. Paradoxically, this was accompanied by an inactivated AMP-activated protein kinase (Ampk), which is normally activated in peripheral tissues during states of low cellular energy. Ampk inactivation correlated with its degradation and with upregulation of the Ampk-interacting protein Cidea. Therefore, we developed an Ampk-stabilizing peptide, ACIP, which was able to ameliorate WAT wasting in vitro and in vivo by shielding the Cidea-targeted interaction surface on Ampk. Thus, our data establish the Ucp1-independent remodeling of adipocyte lipid homeostasis as a key event in tumor-induced WAT wasting, and we propose the ACIP-dependent preservation of Ampk integrity in the WAT as a concept in future therapies for cachexia.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27571348</PMID>
<DateCreated><Year>2016</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>08</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>11</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>22</Volume>
<Issue>10</Issue>
<PubDate><Year>2016</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Nature medicine</Title>
<ISOAbbreviation>Nat. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.</ArticleTitle>
<Pagination><MedlinePgn>1120-1130</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nm.4171</ELocationID>
<Abstract><AbstractText>Cachexia represents a fatal energy-wasting syndrome in a large number of patients with cancer that mostly results in a pathological loss of skeletal muscle and adipose tissue. Here we show that tumor cell exposure and tumor growth in mice triggered a futile energy-wasting cycle in cultured white adipocytes and white adipose tissue (WAT), respectively. Although uncoupling protein 1 (Ucp1)-dependent thermogenesis was dispensable for tumor-induced body wasting, WAT from cachectic mice and tumor-cell-supernatant-treated adipocytes were consistently characterized by the simultaneous induction of both lipolytic and lipogenic pathways. Paradoxically, this was accompanied by an inactivated AMP-activated protein kinase (Ampk), which is normally activated in peripheral tissues during states of low cellular energy. Ampk inactivation correlated with its degradation and with upregulation of the Ampk-interacting protein Cidea. Therefore, we developed an Ampk-stabilizing peptide, ACIP, which was able to ameliorate WAT wasting in vitro and in vivo by shielding the Cidea-targeted interaction surface on Ampk. Thus, our data establish the Ucp1-independent remodeling of adipocyte lipid homeostasis as a key event in tumor-induced WAT wasting, and we propose the ACIP-dependent preservation of Ampk integrity in the WAT as a concept in future therapies for cachexia.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rohm</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schäfer</LastName>
<ForeName>Michaela</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Laurent</LastName>
<ForeName>Victor</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Üstünel</LastName>
<ForeName>Bilgen Ekim</ForeName>
<Initials>BE</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Niopek</LastName>
<ForeName>Katharina</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Algire</LastName>
<ForeName>Carolyn</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hautzinger</LastName>
<ForeName>Oksana</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sijmonsma</LastName>
<ForeName>Tjeerd P</ForeName>
<Initials>TP</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zota</LastName>
<ForeName>Annika</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Medrikova</LastName>
<ForeName>Dasa</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pellegata</LastName>
<ForeName>Natalia S</ForeName>
<Initials>NS</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ryden</LastName>
<ForeName>Mikael</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kulyte</LastName>
<ForeName>Agné</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dahlman</LastName>
<ForeName>Ingrid</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Arner</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Petrovic</LastName>
<ForeName>Natasa</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cannon</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Amri</LastName>
<ForeName>Ez-Zoubir</ForeName>
<Initials>EZ</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-8426-5396</Identifier>
<AffiliationInfo><Affiliation>Université Côte d'Azur, Nice, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Centre National de la Recherche Scientifique (CNRS), Nice, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kemp</LastName>
<ForeName>Bruce E</ForeName>
<Initials>BE</Initials>
<AffiliationInfo><Affiliation>St Vincent's Institute of Medical Research, University of Melbourne, Fitzroy, Victoria, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Mary MacKillop Institute for Health, Research Australian Catholic University, Melbourne, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Steinberg</LastName>
<ForeName>Gregory R</ForeName>
<Initials>GR</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, Division of Endocrinology and Metabolism, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Janovska</LastName>
<ForeName>Petra</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Adipose Tissue Biology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kopecky</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Adipose Tissue Biology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wolfrum</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Swiss Federal Institute of Technology, Institute of Food Nutrition and Health, Schwerzenbach, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Blüher</LastName>
<ForeName>Matthias</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, University of Leipzig, Leipzig, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Berriel Diaz</LastName>
<ForeName>Mauricio</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Herzig</LastName>
<ForeName>Stephan</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>08</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Nat Med</MedlineTA>
<NlmUniqueID>9502015</NlmUniqueID>
<ISSNLinking>1078-8956</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051017">Apoptosis Regulatory Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C112510">Cidea protein, mouse</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000604372">Ucp1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000071256">Uncoupling Protein 1</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="C554549">Prkab1 protein, mouse</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Clin Nutr Metab Care. 2014 Nov;17(6):509-14</RefSource>
<PMID Version="1">25111867</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 1990 Nov;86(5):1403-8</RefSource>
<PMID Version="1">2243120</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cytokine. 2013 Feb;61(2):532-9</RefSource>
<PMID Version="1">23200412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Med. 1980 Oct;69(4):491-7</RefSource>
<PMID Version="1">7424938</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2011 Dec 28;9(1):57-63</RefSource>
<PMID Version="1">22205519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Cardiol. 2008 Jun 2;101(11A):8E-10E</RefSource>
<PMID Version="1">18514632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2005 Jun;54(6):1726-34</RefSource>
<PMID Version="1">15919794</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2015 Apr;58(4):799-808</RefSource>
<PMID Version="1">25596852</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 2011 Jul 8;333(6039):233-8</RefSource>
<PMID Version="1">21680814</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Mar 25;9(3):e92966</RefSource>
<PMID Version="1">24667661</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2003 Sep;35(1):49-56</RefSource>
<PMID Version="1">12910269</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Amino Acids. 2016 Aug;48(8):2015-24</RefSource>
<PMID Version="1">26781304</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Cardiol. 2008 Jan 1;101(1):8-14</RefSource>
<PMID Version="1">18157957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2010 Nov;59(11):2737-46</RefSource>
<PMID Version="1">20693347</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Nutr. 2013 Jan 28;109 (2):302-12</RefSource>
<PMID Version="1">23021109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Lipid Res. 2009 Apr;50(4):704-15</RefSource>
<PMID Version="1">19050316</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2008 Sep;48(3):782-91</RefSource>
<PMID Version="1">18712775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Metab. 2015 Nov 26;5(2):67-78</RefSource>
<PMID Version="1">26909315</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):251-62</RefSource>
<PMID Version="1">22436748</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Methods. 2001 Dec;25(4):402-8</RefSource>
<PMID Version="1">11846609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Prog Mol Biol Transl Sci. 2010;94:39-74</RefSource>
<PMID Version="1">21036322</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Jul 1;280(26):25250-7</RefSource>
<PMID Version="1">15878856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2000;99:63-74</RefSource>
<PMID Version="1">10909077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>FASEB J. 1989 Jun;3(8):1956-62</RefSource>
<PMID Version="1">2721856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2008 Jun 13;283(24):16514-24</RefSource>
<PMID Version="1">18390901</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Metab. 2013 Apr 2;17(4):575-85</RefSource>
<PMID Version="1">23499424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nutr Cancer. 2015;67(1):12-26</RefSource>
<PMID Version="1">25513730</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Obesity (Silver Spring). 2009 Jul;17(7):1312-7</RefSource>
<PMID Version="1">19214174</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1962 Nov;237:3354-8</RefSource>
<PMID Version="1">13996476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Jan 1;285(1):115-22</RefSource>
<PMID Version="1">19892703</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2005 May 27;96(10):1042-52</RefSource>
<PMID Version="1">15920027</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Physiol Scand. 1976 Sep;98(1):8-18</RefSource>
<PMID Version="1">970158</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 1986 Sep 19;233(4770):1318-21</RefSource>
<PMID Version="1">3489291</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Sep;35(9):9291-301</RefSource>
<PMID Version="1">24938873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Treat Options Oncol. 2010 Dec;11(3-4):107-17</RefSource>
<PMID Version="1">21128029</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2011 May;12(5):489-95</RefSource>
<PMID Version="1">21296615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Metab. 2012 Aug 8;16(2):153-66</RefSource>
<PMID Version="1">22795476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Sep 4;513(7516):100-4</RefSource>
<PMID Version="1">25043053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1994 Oct 10;353(1):33-6</RefSource>
<PMID Version="1">7926017</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Surgery. 2012 Sep;152(3 Suppl 1):S81-8</RefSource>
<PMID Version="1">22770957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>EMBO Mol Med. 2013 Feb;5(2):294-308</RefSource>
<PMID Version="1">23307490</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2006 Sep 15;2(9):e146</RefSource>
<PMID Version="1">17002498</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Crit Rev Oncol Hematol. 2011 Oct;80(1):114-44</RefSource>
<PMID Version="1">21216616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 2010 May 28;328(5982):1158-61</RefSource>
<PMID Version="1">20448152</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Cell Physiol. 2012 Dec 1;303(11):C1192-7</RefSource>
<PMID Version="1">23054058</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2008 Oct 1;113(7):1695-704</RefSource>
<PMID Version="1">18704987</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2012 May;32(5):1094-8</RefSource>
<PMID Version="1">22517368</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2010 May;68(2):234-9</RefSource>
<PMID Version="1">19665818</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Semin Cell Dev Biol. 2016 Jun;54:68-81</RefSource>
<PMID Version="1">26529279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2010 Apr;53(4):768-78</RefSource>
<PMID Version="1">20043143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Oct 17;135(2):240-9</RefSource>
<PMID Version="1">18835024</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Metab. 2006 Dec;4(6):465-74</RefSource>
<PMID Version="1">17141630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2013 Dec;19(12):1649-54</RefSource>
<PMID Version="1">24185692</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 1997 May 1;387(6628):90-4</RefSource>
<PMID Version="1">9139827</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Jun 1;67(11):5531-7</RefSource>
<PMID Version="1">17545636</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1990 Apr 15;50(8):2290-5</RefSource>
<PMID Version="1">2317817</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2008 Nov 15;68(22):9247-54</RefSource>
<PMID Version="1">19010897</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Med. 2015 Dec 29;:null</RefSource>
<PMID Version="1">26736177</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2010 Jan 20;29(2):469-81</RefSource>
<PMID Version="1">19942859</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1979 May;43(5 Suppl):2004-12</RefSource>
<PMID Version="1">376104</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Endocrinol Metab. 2011 Oct;301(4):E703-12</RefSource>
<PMID Version="1">21750268</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Metab. 2014 Sep 2;20(3):433-47</RefSource>
<PMID Version="1">25043816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2008 Jun 4;27(11):1537-48</RefSource>
<PMID Version="1">18480843</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2008 Oct;51(10):1893-900</RefSource>
<PMID Version="1">18709353</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D052438" MajorTopicYN="N">Adipocytes, White</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D052436" MajorTopicYN="N">Adipose Tissue, White</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051017" MajorTopicYN="N">Apoptosis Regulatory Proteins</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002100" MajorTopicYN="N">Cachexia</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D050155" MajorTopicYN="N">Lipogenesis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008066" MajorTopicYN="N">Lipolysis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D022722" MajorTopicYN="N">Thermogenesis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000071256" MajorTopicYN="N">Uncoupling Protein 1</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>02</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>07</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>8</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>8</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>8</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27571348</ArticleId>
<ArticleId IdType="pii">nm.4171</ArticleId>
<ArticleId IdType="doi">10.1038/nm.4171</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001743 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001743 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:27571348 |texte= An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27571348" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |